Supplementary material for: Oral Upadacitinib in Vitiligo With Inadequate Response to Prior NB-UVB: A Prospective Case Series
Published: 9 May 2026| Version 2 | DOI: 10.17632/fgjg9r8djs.2
Contributor:
SUQING LIUDescription
Supplementary Figure 1. Representative clinical images from two patients with vitiligo and inadequate response to prior NB-UVB who received oral upadacitinib plus NB-UVB. (A) Responder: 27-year-old female with non-segmental vitiligo. Images obtained at baseline, week 12, and week 24 of combined treatment show repigmentation. (B) Non-responder: 30-year-old female with segmental vitiligo. Images obtained at baseline and week 24 of combined treatment show minimal response, followed by stable repigmentation after suction blister grafting.
Files
Categories
Dermatology